@article{24da5d30946446c09c0565137500bbfe,
title = "Past, present and future use of cytotoxic agents in oncology practice: A systematic review of Pubmed and ClinicalTrials.gov databases: Journal of Oncology Pharmacy Practice",
keywords = "capecitabine, carboplatin, cisplatin, cytotoxic agent, docetaxel, doxorubicin, epirubicin, etoposide, fluorouracil, gemcitabine, ifosfamide, irinotecan, oxaliplatin, paclitaxel, pemetrexed, vinorelbine tartrate, cancer chemotherapy, clinical trial (topic), human, Letter, Medline, oncology, priority journal, systematic review (topic)",
author = "F. Petrelli and A. Damato and G. Perego and A. Ghidini and G. Daniele and C. Pinto",
note = "Export Date: 11 March 2021 CODEN: JOPPF Correspondence Address: Petrelli, F.; Oncology Unit, Italy; email: faustopetrelli@gmail.com Chemicals/CAS: capecitabine, 154361-50-9; carboplatin, 41575-94-4; cisplatin, 15663-27-1, 26035-31-4, 96081-74-2; docetaxel, 114977-28-5; doxorubicin, 23214-92-8, 25316-40-9; epirubicin, 56390-09-1, 56420-45-2; etoposide, 33419-42-0, 433304-61-1; fluorouracil, 51-21-8; gemcitabine, 103882-84-4; ifosfamide, 3778-73-2; irinotecan, 100286-90-6, 97682-44-5; oxaliplatin, 61825-94-3; paclitaxel, 33069-62-4; pemetrexed, 137281-23-3, 150399-23-8, 357166-30-4, 357166-29-1; vinorelbine tartrate, 125317-39-7, 71486-22-1",
year = "2020",
doi = "10.1177/1078155220951237",
language = "English",
volume = "26",
pages = "2069--2072",
journal = "J. Oncol. Pharm. Pract.",
issn = "1078-1552",
publisher = "SAGE Publications Ltd",
number = "8",
}